RT Journal Article
SR Electronic
A1 Mosley, Mary
T1 PreSERVE-AMI: CD34+ Cells Improve Cardiac Function, Reduce Events after STEMI
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 52
SP 24
OP 25
DO 10.1177/155989771452016
UL http://mdc.sagepub.com/content/14/52/24.abstract
AB The intracoronary (IC) infusion of bone marrow mononuclear cells after an STEMI improved cardiac function, including left ventricular ejection fraction, infarct size, and end-systolic volume, and major adverse cardiac events. This article discusses the NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction trial [PreSERVE-AMI; NCT01495364], which looked at IC autologous CD34+ cell therapy for STEMI patients.